Dataset Information


Proteome-wide Analysis Reveals Substrates of E3 Ligase RNF146 Targeted for Degradation.

ABSTRACT: Specific E3 ligases target tumor suppressors for degradation. Inhibition of such E3 ligases may be an important approach to cancer treatment. RNF146 is a RING domain and PARylation-dependent E3 ligase that functions as an activator of the β-catenin/Wnt and YAP/Hippo pathways by targeting the degradation of several tumor suppressors. Tankyrases 1 and 2 (TNKS1/2) are the only known poly-ADP-ribosyltransferases that require RNF146 to degrade their substrates. However, systematic identification of RNF146 substrates have not yet been performed. To uncover substrates of RNF146 that are targeted for degradation, we generated RNF146 knockout cells and TNKS1/2-double knockout cells and performed proteome profiling with label-free quantification as well as transcriptome analysis. We identified 160 potential substrates of RNF146, which included many known substrates of RNF146 and TNKS1/2 and 122 potential TNKS-independent substrates of RNF146. In addition, we validated OTU domain-containing protein 5 and Protein mono-ADP-ribosyltransferase PARP10 as TNKS1/2-independent substrates of RNF146 and SARDH as a novel substrate of TNKS1/2 and RNF146. Our study is the first proteome-wide analysis of potential RNF146 substrates. Together, these findings not only demonstrate that proteome profiling can be a useful general approach for the systemic identification of substrates of E3 ligases but also reveal new substrates of RNF146, which provides a resource for further functional studies.

PROVIDER: S-EPMC7710139 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC3143158 | BioStudies
| S-EPMC6404254 | BioStudies
| S-EPMC4289021 | BioStudies
2017-01-01 | S-EPMC5739769 | BioStudies
| S-EPMC5980575 | BioStudies
| PRJNA656776 | ENA
| S-EPMC4153837 | BioStudies
| S-EPMC5337692 | BioStudies
| S-EPMC6479468 | BioStudies
| S-EPMC7909008 | BioStudies